Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Christine Mcmahon"'
Autor:
Maria Amaya, Christine Mcmahon, Jonathan Aaron Gutman, Marc Schwartz, Brett Sevens, Connor Sohalski, Jennifer Tobin, Clayton Smith, Craig T Jordan, Daniel Aaron Pollyea
Publikováno v:
HemaSphere, Vol 7, p e95778ba (2023)
Externí odkaz:
https://doaj.org/article/51e1c577cf504e6fa7f5e47e3ec7d7f7
Autor:
Jonathan A. Gutman, Amanda Winters, Andrew Kent, Maria Amaya, Christine McMahon, Clayton Smith, Craig T. Jordan, Brett Stevens, Mohammad Minhajuddin, Shanshan Pei, Jeffrey Schowinsky, Jennifer Tobin, Kelly O’Brien, Angela Falco, Elizabeth Taylor, Constance Brecl, Katie Zhou, Phuong Ho, Connor Sohalski, Jessica Dell-Martin, Olivia Ondracek, Diana Abbott, Daniel A. Pollyea
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Venetoclax+azacitidine is the standard of care for newly-diagnosed patients with acute myeloid leukemia (AML) for whom intensive chemotherapy is inappropriate. Efforts to optimize this regimen are necessary. We designed a clinical trial to investigat
Externí odkaz:
https://doaj.org/article/4bed77ea2bb644d486a34c85f8f12b19
Autor:
Michelle L Rosser-Majors, Sandra Rebeor, Christine McMahon, Andrea Wilson, Stephanie L Stubbs, Yolanda Harper, Laura Sliwinski
Publikováno v:
Online Learning, Vol 26, Iss 2 (2022)
Considerable research on effective instruction in the virtual classroom exists. Yet very little is known about the extent to which instructor presence (IP) based on the Community of Inquiry model (CoI), are directly related to retention and student s
Externí odkaz:
https://doaj.org/article/f44e81581c9e4949887b4d6408e05e59
Autor:
Andrew Kent, Marc Schwartz, Christine McMahon, Maria Amaya, Clayton A. Smith, Jennifer Tobin, Kelsey Marciano, Rebecca Rezac, Grace Bosma, Daniel A. Pollyea, Jonathan A. Gutman
Publikováno v:
Bone Marrow Transplantation.
Autor:
Peter L. Greenberg, Richard M. Stone, Aref Al-Kali, John M. Bennett, Uma Borate, Andrew M. Brunner, Wanxing Chai-Ho, Peter Curtin, Carlos M. de Castro, H. Joachim Deeg, Amy E. DeZern, Shira Dinner, Charles Foucar, Karin Gaensler, Guillermo Garcia-Manero, Elizabeth A. Griffiths, David Head, Brian A. Jonas, Sioban Keel, Yazan Madanat, Lori J. Maness, James Mangan, Shannon McCurdy, Christine McMahon, Bhumika Patel, Vishnu V. Reddy, David A. Sallman, Rory Shallis, Paul J. Shami, Swapna Thota, Asya Nina Varshavsky-Yanovsky, Peter Westervelt, Elizabeth Hollinger, Dorothy A. Shead, Cindy Hochstetler
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:106-117
The NCCN Guidelines for Myelodysplastic Syndromes (MDS) provide recommendations for the evaluation, diagnosis, and management of patients with MDS based on a review of clinical evidence that has led to important advances in treatment or has yielded n
Autor:
Diana Abbott, Clayton A. Smith, Julie Rosser, Mohd Minhajuddin, Maria L. Amaya, Jeffrey Schowinsky, Daniel A. Pollyea, Anagha Inguva, Craig T. Jordan, Amanda Winters, Christine McMahon, Jonathan A. Gutman, Audrey Sato, Evan Cherry, Marc Schwartz, Shanshan Pei, Brett M. Stevens
Publikováno v:
Blood Advances
Key Points Patients with AML who received IC were compared with those who received ven to investigate predictors of outcomes.Presence of RUNX1 mutations is associated with better outcomes for ven/aza compared with IC.
Visual Abstract
Veneto
Visual Abstract
Veneto
Autor:
Shanshan Pei, Austin E Gillen, Ian T Shelton, Brett M Stevens, Maura Gasparetto, Krysta Engel, Sarah Staggs, Yanan Wang, William Showers, Anagha Inguva, Maria L Amaya, Mohammad Minhajuddin, Amanda Winters, Sweta B Patel, Hunter Tolison, Anna Krug, Tracy N Young, Jeffrey Schowinsky, Christine McMahon, Clayton A Smith, Daniel A Pollyea, Craig T Jordan
The BCL-2 inhibitor venetoclax has recently emerged as an important component of acute myeloid leukemia (AML) therapy. Notably, use of this agent has revealed a previously unrecognized form of pathogenesis characterized by monocytic disease progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9efe46ddecc25398968ad80a8b273adc
https://doi.org/10.1101/2022.12.04.519036
https://doi.org/10.1101/2022.12.04.519036
Autor:
Craig T. Jordan, Diana Abbott, Daniel A. Pollyea, Jonathan A. Gutman, Marc Schwartz, Clayton A. Smith, Rachel Rabinovitch, Christine McMahon, Amanda Winters
Publikováno v:
Bone Marrow Transplantation. 57:160-166
The combination of venetoclax (ven) and azacitidine (aza) has resulted in high response rates in the upfront treatment of AML in patients age > 75 and patients unfit for intensive chemotherapy. Given the poor historical outcomes in patients age ≥ 6
Autor:
Jeffrey Schowinsky, Christine McMahon, Maria L. Amaya, Craig T. Jordan, Amanda Winters, Marc Schwartz, Evan Cherry, Jonathan A. Gutman, Daniel A. Pollyea, Diana Abbott, Clayton A. Smith
Publikováno v:
Leukemia & Lymphoma. 62:1466-1473
Widely-used response criteria, conditional upon count recovery, were developed for acute myeloid leukemia (AML) in the context of intensive chemotherapy (IC). Extending these definitions to continuously-administered venetoclax-based therapies might u
Publikováno v:
ICERI2021 Proceedings.